Cargando…

Role of Metabolic Reprogramming of Long non-coding RNA in Clear Cell Renal Cell Carcinoma

Renal cell carcinoma (RCC), one of the most frequent cancers, is a "classical" malignancy characterized by metabolic reprogramming. Clear cell renal cell carcinoma (ccRCC) is its most common histopathological subtype. Long-stranded non-coding ribonucleic acids (LncRNAs) are regulatory RNA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Huijie, Yu, Lei, Chen, Jing, Liu, Liting, Yang, Xudong, Cui, Hongwei, Yue, Genquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771523/ https://www.ncbi.nlm.nih.gov/pubmed/35069912 http://dx.doi.org/10.7150/jca.62683

Ejemplares similares

Metabolic reprogramming of clear cell renal cell carcinoma
por: Zhu, Haiyan, et al.
Publicado: (2023)

Knockdown of long noncoding RNA DLEU1 suppresses the progression of renal cell carcinoma by downregulating the Akt pathway
por: Yue, Genquan, et al.
Publicado: (2019)

Integration of Lipidomics and Transcriptomics Reveals Reprogramming of the Lipid Metabolism and Composition in Clear Cell Renal Cell Carcinoma
por: Lucarelli, Giuseppe, et al.
Publicado: (2020)

Construction of the metabolic reprogramming-associated gene signature for clear cell renal cell carcinoma prognosis prediction
por: Tai, Rongfen, et al.
Publicado: (2023)

The platelet isoform of phosphofructokinase contributes to metabolic reprogramming and maintains cell proliferation in clear cell renal cell carcinoma
por: Wang, Jun, et al.
Publicado: (2016)

Identification of novel long non-coding RNAs in clear cell renal cell carcinoma
por: Blondeau, Jasmine JC, et al.
Publicado: (2015)

Mitochondrial metabolic reprogramming-mediated immunogenic cell death reveals immune and prognostic features of clear cell renal cell carcinoma
por: Yang, Lin, et al.
Publicado: (2023)

A metabolic reprogramming-related prognostic risk model for clear cell renal cell carcinoma: From construction to preliminary application
por: Zhang, Qian, et al.
Publicado: (2022)

Identification of HGD and GSTZ1 as Biomarkers Involved Metabolic Reprogramming in Kidney Renal Clear Cell Carcinoma
por: Wang, Jiyan, et al.
Publicado: (2022)

Analysis of long non-coding RNA expression profiles in clear cell renal cell carcinoma
por: Yang, Fei Yan, et al.
Publicado: (2017)

An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma
por: Xu, Yi, et al.
Publicado: (2017)

Identification of autophagy-related long non-coding RNA prognostic and immune signature for clear cell renal cell carcinoma
por: Cui, Yankang, et al.
Publicado: (2021)

Prognostic significance of long non-coding RNAs in clear cell renal cell carcinoma: A meta-analysis
por: Wang, Yan, et al.
Publicado: (2019)

The expression and significance of long non-coding RNA ITGB2-AS1 in renal clear cell carcinoma
por: Zhou, Wei, et al.
Publicado: (2023)

The glucose and lipid metabolism reprogramming is grade-dependent in clear cell renal cell carcinoma primary cultures and is targetable to modulate cell viability and proliferation
por: Bianchi, Cristina, et al.
Publicado: (2017)

A novel prognostic N(7)-methylguanosine-related long non-coding RNA signature in clear cell renal cell carcinoma
por: Luo, Wang, et al.
Publicado: (2023)

Renal Lipid Metabolism Abnormalities in Obesity and Clear Cell Renal Cell Carcinoma
por: Bobulescu, Ion Alexandru, et al.
Publicado: (2021)

A five-long non-coding RNA signature to improve prognosis prediction of clear cell renal cell carcinoma
por: Shi, Da, et al.
Publicado: (2017)

Decreased expression of BRAF-activated long non-coding RNA is associated with the proliferation of clear cell renal cell carcinoma
por: Xue, Sheng, et al.
Publicado: (2018)

A novel prognostic nomogram based on 5 long non-coding RNAs in clear cell renal cell carcinoma
por: Wang, Sheng, et al.
Publicado: (2019)

Immune-related long non-coding RNAs can serve as prognostic biomarkers for clear cell renal cell carcinoma
por: Li, Cheng Shan, et al.
Publicado: (2021)

Multi-Omics Approach Reveals Redox Homeostasis Reprogramming in Early-Stage Clear Cell Renal Cell Carcinoma
por: Zhang, Wei, et al.
Publicado: (2022)

Immunological perspective on the malignant progression of renal clear cell carcinoma
por: Liu, Ji, et al.
Publicado: (2021)

An Effective Hypoxia-Related Long Non-Coding RNAs Assessment Model for Prognosis of Clear Cell Renal Carcinoma
por: Zhang, Han, et al.
Publicado: (2021)

Deficiency of the X-inactivation escaping gene KDM5C in clear cell renal cell carcinoma promotes tumorigenicity by reprogramming glycogen metabolism and inhibiting ferroptosis
por: Zheng, Qian, et al.
Publicado: (2021)

Metastatic Immune-Related Genes for Affecting Prognosis and Immune Response in Renal Clear Cell Carcinoma
por: Sun, Si, et al.
Publicado: (2022)

A Novel Prognostic Model Based on Autophagy-Related Long Non-Coding RNAs for Clear Cell Renal Cell Carcinoma
por: Li, Xinyuan, et al.
Publicado: (2021)

A novel autophagy-related long non-coding RNAs prognostic risk score for clear cell renal cell carcinoma
por: Tang, Fucai, et al.
Publicado: (2022)

Systematic Review: ClearCode 34 – A Validated Prognostic Signature in Clear Cell Renal Cell Carcinoma (ccRCC)
por: Ghatalia, Pooja, et al.
Publicado: (2018)

Clinical Implications of HSC70 Expression in Clear Cell Renal Cell Carcinoma
por: Zhang, Yixiao, et al.
Publicado: (2021)

Current Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma
por: Barth, Dominik A., et al.
Publicado: (2019)

Comprehensive Analysis of the Immune Infiltrates of Pyroptosis in Kidney Renal Clear Cell Carcinoma
por: Sun, Zhuolun, et al.
Publicado: (2021)

Integrative 5-Methylcytosine Modification Immunologically Reprograms Tumor Microenvironment Characterizations and Phenotypes of Clear Cell Renal Cell Carcinoma
por: Xu, Wenhao, et al.
Publicado: (2021)

A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma
por: Pichler, Renate, et al.
Publicado: (2023)

A Novel Prognostic Ferroptosis-Related Long Noncoding RNA Signature in Clear Cell Renal Cell Carcinoma
por: Bai, Zhixun, et al.
Publicado: (2022)

Genome instability-related long non-coding RNA in clear renal cell carcinoma determined using computational biology
por: Wang, Yutao, et al.
Publicado: (2021)

Metabolic Understanding of the Genetic Dysregulation in the Tumor Microenvironment of Kidney Renal Clear Cell Carcinoma
por: Xie, Junwei, et al.
Publicado: (2022)

Global Characterization of Immune Infiltration in Clear Cell Renal Cell Carcinoma
por: Zheng, Yan, et al.
Publicado: (2021)

Dysregulation of Long Non-coding RNAs and mRNAs in Plasma of Clear Cell Renal Cell Carcinoma Patients Using Microarray and Bioinformatic Analysis
por: Zhang, Bing, et al.
Publicado: (2020)

Glycogen metabolism is dispensable for tumor progression in clear cell renal cell carcinoma
por: Xie, Hong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o7e2rfh0klvu2p0qa43ohnpsvt